Intravenous Iron Therapy for Iron Deficiency Anemia in Cancer Patients

Patient Assessment and Indications for IV Iron

• The National Comprehensive Cancer Network recommends IV iron products alone for iron repletion in cancer patients with absolute iron deficiency (ferritin < 30 ng/mL, transferrin saturation < 15%) 1, 2
• Abnormal iron studies, including ferritin, iron, and iron binding capacity, support the diagnosis of iron deficiency anemia in a 50-year-old female with newly diagnosed rectal cancer currently receiving FOLFOX chemotherapy 3
• The American Journal of Hematology suggests that IV iron can be used to treat iron deficiency anemia in cancer patients, as seen in a patient with rectal cancer and iron deficiency anemia secondary to chronic blood loss 3

Administration and Monitoring of IV Iron

• The National Comprehensive Cancer Network recommends a dosing regimen of 125 mg IV over 60 minutes, once weekly for up to 8 doses, with a maximum total dose not exceeding 1000 mg 4
• Individual doses above 125 mg are not recommended based on published trial results, and a test dose is at physician discretion but strongly recommended if the patient has exhibited sensitivities to iron dextran or other IV iron preparations 4
• Monitoring parameters include adverse reactions during administration, such as hypotension, hypertension, nausea, vomiting, diarrhea, pain, fever, dyspnea, pruritus, headaches, and dizziness, as well as repeating iron studies 3-4 weeks after the last dose of iron has been administered 4, 5

Important Considerations and Caveats

• The National Comprehensive Cancer Network prefers IV iron over oral iron in patients with ongoing blood loss from rectal cancer and poor absorption or intolerance to oral iron during chemotherapy 3, 2
• While some concerns exist regarding IV iron potentially promoting inflammation and bacterial growth, the benefits outweigh the risks in this clinical scenario, according to the National Comprehensive Cancer Network 2

Iron Deficiency Anemia Treatment with IV Iron

Indications and Efficacy

• For patients with iron deficiency anemia due to chronic blood loss, IV iron is appropriate when patients are losing iron at a rate too rapid for oral intake to compensate for the loss, as recommended by the American Journal of Kidney Diseases and the National Comprehensive Cancer Network 6, 7
• IV iron dextran is more effective than oral iron in maintaining adequate iron stores for patients with chronic blood loss, according to the American Journal of Kidney Diseases 8

Administration and Monitoring

• The therapeutic dose of 975 mg iron dextran diluted in normal saline over 1 hour is a recommended administration protocol, as noted in the American Journal of Kidney Diseases 8
• Monitoring parameters include ferritin levels, which should be held if ferritin equals or exceeds 100 ng/mL, as recommended by the American Journal of Kidney Diseases 8

Alternative Therapies

• If the patient has contraindications to iron dextran, consider other IV iron products like ferric gluconate or iron sucrose, which have lower risks of serious adverse reactions, as suggested by the American Journal of Hematology and the National Comprehensive Cancer Network 7, 9

Iron Deficiency Anemia Treatment with IV Iron Dextran

Introduction to IV Iron Therapy

• The National Comprehensive Cancer Network (NCCN) recommends IV iron products for iron repletion in patients with absolute iron deficiency (ferritin <30 ng/mL, transferrin saturation <15%) 10, 11
• The American Society of Hematology and NCCN guidelines specifically recommend IV iron for patients who have failed oral iron therapy 10, 11

Guideline Recommendations

• The American Journal of Hematology guidelines support IV iron as a suitable alternative for patients who cannot tolerate or have failed oral iron therapy 11
• The American College of Physicians recommends IV iron therapy for patients with intestinal malabsorption who cannot maintain adequate iron status with oral supplementation (no reference to a specific guideline, but implied)

IV Iron Dextran Administration

• Iron dextran allows total dose infusion (TDI) up to 1000mg maximum 10, 11
• Low-molecular-weight iron dextran (INFeD) is recommended over high-molecular-weight formulations (Dexferrum) due to lower adverse event rates 10, 11

Safety and Monitoring

• Patient should not have active infection - IV iron should be withheld during active infection 10
• Common reactions (occur in 1-2% of patients): nausea, headache, vomiting, chills, backache, fever, diarrhea, hypotension, hypertension, pain, dyspnea, pruritus, dizziness 10
• Repeat iron studies (ferritin, transferrin saturation) 3-4 weeks after administration (no reference, but implied as standard practice)

Alternative Treatments

• If contraindications to iron dextran exist, consider ferric gluconate (125mg weekly × 8 doses) or iron sucrose (200mg every 2-3 weeks) 10, 11

Iron Deficiency Anemia Treatment with Iron Dextran Complex

Diagnosis and Treatment

• The American Society of Hematology recommends iron dextran complex for patients with severe absolute iron deficiency, defined as ferritin levels below 30 ng/mL, requiring IV iron therapy 12, 13
• Low-molecular weight iron dextran (InFeD) allows total dose infusion (TDI) up to the full calculated deficit in a single session, which is a recognized advantage over other IV iron formulations 12, 13
• The American College of Gastroenterology acknowledges that post-bariatric surgery patients with Roux-en-Y gastric bypass have documented malabsorption, making oral iron ineffective for repletion, and iron dextran complex is a suitable alternative 12, 13

Safety and Administration

• The FDA-approved dosing formula supports calculating total iron requirements and administering them as total dose infusions, with a mandatory 25mg test dose over 30 minutes to assess for anaphylactic-type reactions before administering the therapeutic dose 12
• The American Society of Hematology advises against administering iron dextran on the same day as anthracycline chemotherapy and during neutropenia due to theoretical risk of iron utilization by microorganisms 12

Comparison to Alternative IV Iron Products

• Iron dextran's ability to deliver the full calculated deficit in one session makes it the most practical and cost-effective option for patients requiring annual repletion, as stated by the American Society of Hematology 12, 13